KR100526944B1 - Dandelion granular tea and process for preparing the same - Google Patents

Dandelion granular tea and process for preparing the same Download PDF

Info

Publication number
KR100526944B1
KR100526944B1 KR1020040038613A KR20040038613A KR100526944B1 KR 100526944 B1 KR100526944 B1 KR 100526944B1 KR 1020040038613 A KR1020040038613 A KR 1020040038613A KR 20040038613 A KR20040038613 A KR 20040038613A KR 100526944 B1 KR100526944 B1 KR 100526944B1
Authority
KR
South Korea
Prior art keywords
dandelion
extract
weight
parts
tea
Prior art date
Application number
KR1020040038613A
Other languages
Korean (ko)
Inventor
최희돈
박용곤
석호문
최인욱
김윤숙
Original Assignee
한국식품연구원
임실군
재단법인 전라북도생물산업진흥원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국식품연구원, 임실군, 재단법인 전라북도생물산업진흥원 filed Critical 한국식품연구원
Priority to KR1020040038613A priority Critical patent/KR100526944B1/en
Application granted granted Critical
Publication of KR100526944B1 publication Critical patent/KR100526944B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/06Treating tea before extraction; Preparations produced thereby
    • A23F3/14Tea preparations, e.g. using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/06Treating tea before extraction; Preparations produced thereby
    • A23F3/12Rolling or shredding tea leaves
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/16Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/163Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/16Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/18Extraction of water soluble tea constituents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/16Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/22Drying or concentrating tea extract
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/34Tea substitutes, e.g. matè; Extracts or infusions thereof

Abstract

본 발명은 민들레 잎 추출물, 민들레 뿌리 추출물, 상백피 추출물 및 당삼 추출물을 포함하는 민들레 과립차 및 그의 제조방법에 관한 것이다. 본 발명의 민들레 과립차의 제조방법은 (ⅰ) 포도당 100중량부, 50 내지 70Brix의 민들레 잎 열수추출액 9 내지 12중량부, 50 내지 70Brix의 민들레 뿌리 열수추출액 3 내지 4중량부, 50 내지 70Brix의 상백피 열수추출액 2 내지 4중량부 및 50 내지 70Brix의 당삼 열수추출액 2 내지 4중량부를 혼합하는 공정; (ⅱ) 전기 혼합물을 농축하고 제립하여, 과립을 수득하는 공정; 및, (ⅲ) 전기 수득한 과립을 건조시키는 공정을 포함한다. 본 발명의 민들레 과립차는 치매예방효과가 우수할 뿐만 아니라, 기호성이 우수하므로, 치매예방을 위한 기능성 식품으로서 널리 활용될 수 있을 것이다.The present invention relates to a dandelion granule tea comprising a dandelion leaf extract, dandelion root extract, lettuce extract and sugar extract and a method for producing the same. Method for producing dandelion granulated tea of the present invention (i) 100 parts by weight of glucose, 9 to 12 parts by weight of dandelion leaf hot water extract of 50 to 70 Brix, 3 to 4 parts by weight of dandelion root hot water extract of 50 to 70 Brix, 50 to 70 Brix Mixing 2 to 4 parts by weight of hot water extract and 2 to 4 parts by weight of 50 to 70 Brix of sugar ginseng hot water extract; (Ii) concentrating and granulating the mixture to obtain granules; And (iii) drying the obtained granules. Dandelion granule tea of the present invention is not only excellent dementia prevention effect, but also excellent palatability, it can be widely used as a functional food for preventing dementia.

Description

민들레 과립차 및 그의 제조방법{Dandelion Granular Tea and Process for Preparing the Same}Dandelion Granular Tea and Process for Preparing the Same

본 발명은 민들레 과립차 및 그의 제조방법에 관한 것이다. 좀 더 구체적으로, 본 발명은 민들레 잎 추출물, 민들레 뿌리 추출물, 상백피 추출물 및 당삼 추출물을 포함하는 민들레 과립차 및 그의 제조방법에 관한 것이다.The present invention relates to a dandelion granulated tea and a method of manufacturing the same. More specifically, the present invention relates to a dandelion granule tea comprising a dandelion leaf extract, dandelion root extract, lettuce extract and sugar extract and a method for producing the same.

노인성 치매는 환자의 뇌에서 β-아밀로이드 펩티드(β-amyloid peptide)가 노인반과 신경섬유다발을 형성하여 콜린(choline)성 신경계 등 여러 신경계의 퇴행성 병변을 진행시키기 때문에, 유발되는 것으로 알려져 있다. 현재, 65세 이상의 노인 인구의 약 10%, 75세 이상의 노인 인구의 약 25%, 85세 이상의 노인 인구의 약 50%에서 노인성 치매 질환이 발생하고 있으며, 이러한 치매 환자는 앞으로도 지속적으로 증가될 것으로 예상되기 때문에, 치매질환은 인류가 당면할 최대의 보건문제로 등장하고 있다. 노인성 치매가 발병된 경우, 뇌 내의 아세틸콜린(acetylcholine) 등의 신경전달물질이 감소하는 것으로 확인되고 있어, 뇌 내 콜린(choline)성 기능을 항진시켜 노인성 치매의 제증상을 완화시키려는 목적으로 개발되어 판매되고 있는 아세틸콜린 에스터라제(acetylcholine esterase, AChE)의 저해제인 태크린(tacrine), ENA 713 등이 치매치료제로서 이용되고 있으나, 임상에서 이들 약물의 유효성이 낮고, 치매의 심각한 증상의 발현을 지연시키는 정도로 활용되고 있는 실정이다. Geriatric dementia is known to be caused by β-amyloid peptides in the brain of the patient to form neurofibrillary bundles with the senile plaques and to advance degenerative lesions of various nervous systems such as the choline nervous system. Currently, about 10% of the elderly aged 65 or older, about 25% of the aged 75 or older, and about 50% of the aged aged 85 or older are suffering from senile dementia. As expected, dementia disease is emerging as the biggest health problem facing humanity. When senile dementia develops, it has been confirmed that neurotransmitters such as acetylcholine in the brain are reduced, and is developed to alleviate symptoms of senile dementia by promoting choline function in the brain. Although tacrine and ENA 713, which are commercially available inhibitors of acetylcholine esterase (AChE), have been used as treatments for dementia, the effectiveness of these drugs in the clinical practice and the development of severe symptoms of dementia are low. The situation is being used to delay.

치매에 의하여 유발된 중추신경계의 손상은 복구가 불가능함을 감안한다면, 실질적으로 치매를 치료하는 가장 바람직한 방법은 치매 환자의 두뇌에서 특징적으로 나타나는 베타 아밀로이드 플라그(beta amyloid plaque)의 생성을 저해하거나 또는 베타 아밀로이드에 의한 신경세포의 사멸을 방지하는 것이다. 전기 플라그는 뉴런 신경세포(neuronal cell)의 손실 및 치매의 발현을 유도하는 것으로 알려져 있기 때문에, 두뇌에서 베타 아밀로이드 플라그의 생성을 억제하거나 또는 이의 축적을 감소시킴으로써, 치매의 발병 및 진행을 막을 수 있을 것으로 예측되고 있다. 이에 따라, 베타 아밀로이드 플라그의 형성을 억제할 수 있는 물질을 찾기 위한 연구가 활발히 진행되고 있으며, 그 결과, 약독화된 베타 아밀로이드를 이용한 백신이 효과적임이 보고되었으나, 뇌손상, 면역거부반응 등의 부작용이 치명적인 문제점으로 대두되었다Given that the damage to the central nervous system caused by dementia is irreversible, the most effective way to treat dementia is to inhibit the production of beta amyloid plaques that are characteristic of the brains of dementia patients. It is to prevent neuronal death by beta amyloid. Since electric plaques are known to induce neuronal cell loss and expression of dementia, it may be possible to prevent the development and progression of dementia by inhibiting the production of beta amyloid plaques or reducing their accumulation in the brain. It is expected to be. Accordingly, studies are actively conducted to find a substance that can inhibit the formation of beta amyloid plaques. As a result, a vaccine using attenuated beta amyloid has been reported to be effective, but side effects such as brain damage and immune rejection reactions have been reported. This fatal issue has emerged

이에, 두뇌에서 베타 아밀로이드 플라그의 형성을 억제하여 치매의 발병 및 진행을 예방할 수 있으면서도, 부작용이 없이 상식(常食)할 수 있는 물질을 함유하는 식품 등을 섭식함으로써, 부작용이 없이 치매를 예방할 수 있을 것으로 기대되고 있으나, 아직까지는 별다른 성과가 보고되지 않고 있는 실정이다.Therefore, it is possible to prevent the development and progression of dementia by inhibiting the formation of beta amyloid plaques in the brain, and to feed on foods containing substances that can be common sense without side effects, thereby preventing dementia without side effects. Although it is expected to be expected, no results have been reported so far.

따라서, 치매의 발병 및 진행을 억제할 수 있으며, 안전성이 확보되어 부작용이 없이 상식할 수 있는 물질을 개발하여야 할 필요성이 끊임없이 대두되었다.Therefore, the necessity to develop a substance that can suppress the onset and progress of dementia, and ensure safety and common sense without side effects has emerged constantly.

이에, 본 발명자들은 치매의 발병 및 진행을 억제할 수 있으며, 안전성이 확보되어 부작용이 없이 상식할 수 있는 물질을 개발하고자 예의 연구 노력한 결과, 고래로부터 한약재로 상용해 온 민들레가 β-아밀로이드 펩티드에 의한 신경세포의 손상을 억제시키는 효과를 나타내고, 한약재로서 사용되는 상백피와 당삼에서 수득한 추출물이 첨가될 경우, 전기 민들레의 효과가 배가됨을 알 수 있었으므로, 전기 민들레, 상백피 및 당삼의 효과를 활용하기 위하여, 민들레 추출물, 상백피 추출물 및 당삼 추출물을 포함하는 민들레 과립차를 제조한 결과, 전기 민들레 과립차가 부작용이 없이 치매의 발병 및 진행을 억제할 수 있음을 확인하고, 본 발명을 완성하게 되었다. Thus, the present inventors can suppress the development and progression of dementia, and as a result of earnest research to develop a substance that can secure common sense without side effects as a result of safety, dandelion commercially available as a herbal medicine from whales in β-amyloid peptide It shows the effect of inhibiting the damage of nerve cells caused by, and when the extract obtained from baekryepi and ginseng used as a medicinal herb was found to double the effect of the electric dandelion, utilizing the effects of electric dandelion, baekryepi and sugar ginseng In order to produce a dandelion granule tea comprising a dandelion extract, an extract of lettuce and extract of Dangsam, it was confirmed that the electric dandelion granule tea can suppress the onset and progression of dementia without side effects, and completed the present invention.

결국, 본 발명의 주된 목적은 민들레 추출물, 상백피 추출물 및 당삼 추출물을 포함하고, 치매예방 효과를 나타내는 민들레 과립차를 제공하는 것이다.After all, the main object of the present invention is to provide a dandelion granule tea, including dandelion extract, lettuce extract, and ginseng extract, exhibiting a dementia prevention effect.

본 발명의 다른 목적은 전기 민들레 과립차의 제조방법을 제공하는 것이다. Another object of the present invention is to provide a method for producing an electric dandelion granular tea.

본 발명의 민들레 과립차의 제조방법은 (ⅰ) 포도당 100중량부, 50 내지 70Brix의 민들레 잎 열수추출액 9 내지 12중량부, 50 내지 70Brix의 민들레 뿌리 열수추출액 3 내지 4중량부, 50 내지 70Brix의 상백피 열수추출액 2 내지 4중량부 및 50 내지 70Brix의 당삼 열수추출액 2 내지 4중량부를 혼합하는 공정; (ⅱ) 전기 혼합물을 농축하고 제립하여, 과립을 수득하는 공정; 및, (ⅲ) 전기 수득한 과립을 건조시키는 공정을 포함한다.Method for producing dandelion granulated tea of the present invention (i) 100 parts by weight of glucose, 9 to 12 parts by weight of dandelion leaf hot water extract of 50 to 70 Brix, 3 to 4 parts by weight of dandelion root hot water extract of 50 to 70 Brix, 50 to 70 Brix Mixing 2 to 4 parts by weight of hot water extract and 2 to 4 parts by weight of 50 to 70 Brix of sugar ginseng hot water extract; (Ii) concentrating and granulating the mixture to obtain granules; And (iii) drying the obtained granules.

민들레(Taraxacum herba)는 한방명으로 포공영(浦公英)이라고도 지칭되는 국화과(Compositae)에 속하는 다년산 초본으로서, 이른봄부터 늦가을에 이르기까지 우리나라 전역에 걸쳐 널리 분포하고 있다. 고대로부터 민들레는 뿌리, 잎, 꽃, 줄기 등 식물체 모두를 약용할 수 있는 몇 안되는 약초로 알려져 왔다.Dandelion ( Taraxacum herba ) is a perennial herb belonging to the genus Apothecara, also known as Pogongyoung, and is widely distributed throughout Korea from early spring to late autumn. From ancient times, dandelion has been known as one of the few herbs that can medicinal all the plants, such as roots, leaves, flowers, stems.

한방에서는, 민들레의 맛은 쓰고 짜며 성질은 평(平)하고 한(寒)하나 독이 없다고 평가되고 있다. 동의보감에는 민들레는 열을 내리고 해독과 이뇨, 최유(催乳)효과가 있고, 울결(鬱結)을 풀어주거나 염증이나 종기를 낫게 하며, 간과 담낭질환의 치료에 이용된다고 기재되어 있고, 본초강목(本草綱目)에는 민들레즙을 계속 마시면 머리카락이 검어지고 위와 골이 튼튼해 진다고 하였으며, 본초정의(本草定議)에서는 포공영의 성질이 청량하여 열독, 홍종(紅腫), 창정, 옹양(癰瘍)의 치료에 내복과 외용이 모두 가능하며 그 효과가 대단히 크다고 기재되어 있다. 또한, 민간요법에 의하면, 민들레는 강장, 해열, 이뇨, 건위, 거담, 해독제 등에 이용되어 왔으며, 서양에서도 담즙분비 촉진, 항류마티스, 이뇨 등의 작용으로 약제로 사용되고 있다. In oriental medicine, the taste of dandelion is bitter and salty, and the property is flat and it is evaluated that it is not poisonous. Dongbogam describes dandelion as a fever, detoxification, diuresis, and the most effective effect, it is used for the treatment of liver and gallbladder disease, to relieve the ulcers and to relieve inflammation or boil. ) Dandelion juice continued to darken the hair and to strengthen the stomach and bones. It is possible to use both externally and externally, and the effect is stated to be very large. In addition, according to folk remedies, dandelion has been used in tonic, antipyretic, diuretic, healthy, expectorant, antidote, etc., and is also used in the West as a drug for promoting bile secretion, antirheumatic, diuretic and the like.

본 발명자들은 체내에 부작용이 없이 치매의 발병 및 진행을 억제할 수 있는 물질을 개발하기 위하여 연구하던 중, 고래로부터 한약재로 상용해 온 민들레가 β-아밀로이드 펩티드에 의한 신경세포의 손상을 억제시키는 효과를 나타내고, 치매 증상의 진행과 관련된 것으로 알려진 아세틸콜린 에스터라제(acetylcholine esterase, AChE)에 대한 저해활성을 나타내는 한약재인 상백피와 당삼이 β-아밀로이드 펩티드에 의한 신경세포의 손상을 억제시키는 민들레의 효과를 배가시킴을 확인할 수 있었다.The present inventors have been studying to develop a substance that can suppress the development and progression of dementia without side effects in the body, and the effect of dandelion, which has been commonly used as a medicinal herb from whales, suppresses the damage of nerve cells by β-amyloid peptide. Effect of dandelion on inhibiting neuronal cell damage caused by β-amyloid peptides of lettuce and red ginseng, which are herbal medicines showing inhibitory activity against acetylcholine esterase (AChE), which is known to be related to the progression of dementia symptoms It could be confirmed that hungry.

상기 결과로부터, 본 발명자들은 민들레, 상백피 및 당삼을 사용할 경우, 치매예방 효과를 나타냄을 알 수 있었는 바, 이들을 부작용이 없이 상식(常食)할 수 있는 다양한 식품의 형태로 제조하고자 노력한 결과, 민들레 잎 추출물, 민들레 뿌리 추출물, 상백피 추출물 및 당삼 추출물을 포함하는 민들레 과립차를 제조하게 되었고, 전기 제조된 민들레 과립차가 β-아밀로이드 펩티드에 의한 신경세포의 손상을 효과적으로 억제시킬 수 있음을 확인할 수 있었다: 이때, 민들레 과립차에 첨가되는 민들레 잎 추출액의 함량은 특별히 이에 제한되지 않으나, 당류 100중량부에 대하여 9 내지 12중량부로 첨가됨이 바람직하고, 민들레 뿌리 추출액의 함량은 특별히 이에 제한되지 않으나, 당류 100중량부에 대하여 3 내지 4중량부로 첨가됨이 바람직하며, 상백피 추출액의 함량은 특별히 이에 제한되지 않으나, 당류 100중량부에 대하여 2 내지 4중량부로 첨가됨이 바람직하고, 당삼 추출액의 함량은 특별히 이에 제한되지 않으나, 당류 100중량부에 대하여 2 내지 4중량부로 첨가됨이 바람직하다.From the above results, the present inventors have been found that the use of dandelion, baekryepi and ginseng showed dementia-preventing effect, as a result of trying to prepare them in the form of various foods that can be common sense without side effects, dandelion leaves Dandelion granulated tea comprising the extract, dandelion root extract, lettuce extract, and ginseng extract was prepared, and it was confirmed that the dandelion granulated tea, which was previously prepared, can effectively inhibit neuronal damage caused by β-amyloid peptide: The content of the dandelion leaf extract added to the dandelion granule tea is not particularly limited thereto, but is preferably added in an amount of 9 to 12 parts by weight based on 100 parts by weight of sugar, and the content of the dandelion root extract is not particularly limited thereto, but is 100 parts by weight of sugar. It is preferably added in an amount of 3 to 4 parts by weight, The content of the liquid is not particularly limited thereto, but is preferably added in an amount of 2 to 4 parts by weight based on 100 parts by weight of sugar, and the content of the extract is not particularly limited thereto, but is added in an amount of 2 to 4 parts by weight based on 100 parts by weight of sugar. Is preferred.

본 발명의 민들레 과립차는 β-아밀로이드 펩티드에 의한 신경세포의 손상을 효과적으로 억제시킬 수 있을 뿐만 아니라, 기호성이 우수하므로, 치매예방을 위한 기능성 식품으로서 널리 활용될 수 있을 것이다.Dandelion granular tea of the present invention can effectively inhibit the damage of neurons by β-amyloid peptide, and also has excellent palatability, and thus can be widely used as a functional food for preventing dementia.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 국한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention in more detail, it will be apparent to those skilled in the art that the scope of the present invention is not limited to these examples.

실시예 1: 민들레 추출물의 제조 및 치매예방효과 분석 Example 1 Preparation of Dandelion Extract and Analysis of Dementia Prevention Effect

실시예 1-1: 민들레 추출물의 제조 Example 1-1 Preparation of Dandelion Extract

민들레의 부위별로 동결건조한 분말에 메탄올을 사용하여 추출물을 제조하였다. 즉, 흰민들레와 노랑민들레의 부위별(잎, 뿌리) 분말 5g을 각각 100mL의 75%(v/v) 메탄올 수용액에 현탁시킨 후, 80℃에서 3시간 환류추출하고, 여과하여 수득한 액상성분을 45℃에서 진공농축기에서 농축한 다음, 이를 동결건조하여 민들레 추출물을 제조하였다.Extracts were prepared using methanol to lyophilized powder for each part of the dandelion. That is, 5 g of the powders (leaves and roots) of the white and yellow dandelions were suspended in 100 mL of 75% (v / v) aqueous methanol solution, respectively, and then refluxed at 80 ° C. for 3 hours and filtered to obtain liquid components. Was concentrated in a vacuum concentrator at 45 ℃, and then lyophilized to prepare a dandelion extract.

실시예 1-2: 민들레 추출물의 치매예방효과 분석 Example 1-2 : Dementia Prevention Effect Analysis of Dandelion Extract

뇌신경암 유래 세포주 SK-N-SH(MedXBio Inc., USA)를 신경세포 배양배지(10%(v/v) FBS, 1mM sodium pyruvate, 1% penicillin-streptomycin, Dulbecco modified Eagle's minimum essential medium(DMEM))에 세포수가 5 ×105cells/mL가 되도록 분주하여 37℃, 5%(v/v) CO2 배양기에서 일주일에 2회 배지를 교체하며 단층 배양하였다. 이렇게 배양된 세포에 40μM의 β-amyloid peptide1-42(βA, American Peptide Company, USA) 를 처리하고, 전기 제조된 각각의 민들레 추출물을 0.01, 0.05, 0.1, 0.25 및 0.5mg/ml의 농도로 처리한 후, 신경세포의 생존율을 측정하였다. 이때, 음성 대조군으로는 βA와 민들레 추출물이 처리되지 않은 신경세포를 사용하고, 양성 대조군으로는 민들레 추출물이 처리되지 않은 신경세포를 사용하였다.Cerebral nerve cancer-derived cell line SK-N-SH (MedXBio Inc., USA) was cultured in neuronal cell culture medium (10% (v / v) FBS, 1 mM sodium pyruvate, 1% penicillin-streptomycin, Dulbecco modified Eagle's minimum essential medium (DMEM)). The cells were divided into 5 × 10 5 cells / mL, and cultured in a single layer, replacing the medium twice a week in a 37 ° C., 5% (v / v) CO 2 incubator. The cultured cells were treated with 40 μM of β-amyloid peptide 1-42 (βA, American Peptide Company, USA), and each of the dandelion extracts prepared at the concentrations of 0.01, 0.05, 0.1, 0.25 and 0.5 mg / ml. After treatment, the survival rate of neurons was measured. At this time, βA and dandelion extract were treated as a negative control neuron, and a positive control was used as a dandelion extract untreated neuron.

또한, 전기 신경세포의 생존율은 MTT(3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide) 분석법에 따라, 생존세포의 수를 계수하여 측정하였다: 즉, 전기 배양된 각 세포를 파쇄하여 세포 현탁액을 수득하고, 전기 현탁액에 MTT 용액(2.5mg/mL H2O) 100μL를 첨가하여 37℃에서 4시간 동안 반응시킨 후, 1500rpm으로 원심분리하여 침전물을 수득한 다음, 침전물에 디메틸설폭사이드(dimethyl sulfoxide, DMSO) 100μL를 첨가하여, 침전물을 용해시키고 540nm에서 흡광도를 측정하였다(참조: 표 1).In addition, the survival rate of the electric neurons was measured by counting the number of viable cells according to the MTT (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazoliumbromide) assay: that is, each of the cultured cells The cells were crushed to obtain a cell suspension, 100 μL of MTT solution (2.5 mg / mL H 2 O) was added to the suspension and reacted at 37 ° C. for 4 hours, followed by centrifugation at 1500 rpm to obtain a precipitate. 100 μL of dimethyl sulfoxide (DMSO) was added to the precipitate to dissolve the precipitate and the absorbance was measured at 540 nm (see Table 1).

민들레 추출물 및 그의 농도에 따른 신경세포의 생존율(단위: %)Dandelion extract and survival rate of neurons according to its concentration (%) 민들레 추출물Dandelion extract 0.01mg/ml0.01mg / ml 0.05mg/ml0.05mg / ml 0.1mg/ml0.1mg / ml 0.25mg/ml0.25mg / ml 0.5mg/ml0.5mg / ml 음성 대조군Negative control 100100 100100 100100 100100 100100 양성 대조군Positive control 6060 6060 6060 6060 6060 흰민들레 잎White dandelion leaf 6868 7272 6565 6767 100100 흰민들레 뿌리White dandelion root 6161 6161 6262 6868 7878 노랑민들레 잎Yellow dandelion leaf 6161 7171 7575 8282 100100 노랑민들레 뿌리Yellow dandelion root 6161 6565 6868 7373 100100

상기 표 1에서 보듯이, 흰민들레와 노랑민들레의 잎의 경우, 0.5mg/mL의 매우 낮은 농도의 추출물이 첨가되어도 세포생존율이 정상대조군 수준으로 회복되었고, 이보다 낮은 0.05mg/mL의 농도에서도 높은 생존율을 나타내었다. 그러나, 뿌리의 경우, 흰민들레보다는 노랑민들레가 높은 생존율을 나타냄을 알 수 있었다.As shown in Table 1, in the case of leaves of white dandelion and yellow dandelion, even if the extract of very low concentration of 0.5mg / mL was added to the cell survival rate was restored to the normal control level, even at a concentration of 0.05mg / mL lower than this high Survival was shown. However, it was found that yellow dandelions showed higher survival rates than white dandelions.

실시예 2: 아세틸콜린 에스터라제(acetylcholine esterase, AChE) 저해활성을 갖는 생약재의 탐색 Example 2 Screening of Herbal Medicines Having Inhibitory Activity of Acetylcholine Esterase (AChE)

실시예 2-1: AChE 저해활성을 갖는 생약재의 탐색 Example 2-1 : Search for herbal medicines having AChE inhibitory activity

20여종의 생약재 5g을 100mL의 75% 메탄올에 현탁시킨 후, 80℃에서 3시간 환류추출하고 여과한 여액을 45℃ 진공농축기에서 농축한 다음, 이를 동결건조하여 각각의 추출물을 수득하였다.5 g of 20 herbal medicines were suspended in 100 mL of 75% methanol, refluxed at 80 ° C. for 3 hours, the filtrate was concentrated in a 45 ° C. vacuum concentrator, and lyophilized to obtain each extract.

AChE 저해활성은 다음과 같은 방법으로 측정하였다: 즉, 0.1M 인산염 완충용액(pH 8.0) 170uL, 2mM 디티오비스니트로벤조산(dithiobisnitrobenzoic acid) 20uL, 전기 수득한 추출물을 0.5, 1, 2.5 및 5mg/ml의 농도로 1ml의 메탄올에 용해시킨 용액 20uL 및 AChE 20uL(0.2unit)의 혼합액 230uL를 37℃에서 10분간 전처리하고, 3.75mM 아세틸콜린 요오드(acetylcholine iodide) 20uL를 첨가한 다음, 37℃에서 30분간 반응시키고, 410nm에서 흡광도(A)를 측정하였다. 또한, 0.1M 인산염 완충용액(pH 8.0)과 전기 수득한 추출물을 0.5, 1, 2.5 및 5mg/ml의 농도로 1ml의 메탄올에 용해시킨 용액 20uL의 혼합액을 410nm에서 흡광도(B)를 측정하였다. 아울러, 대조구로는 메탄올을 410nm에서 측정한 흡광도를 사용하여, 하기의 식에 의하여 AChE 저해활성을 측정하였다(참조: 표 2).AChE inhibitory activity was determined by the following methods: 170 uL of 0.1 M phosphate buffer (pH 8.0), 20 uL of 2 mM dithiobisnitrobenzoic acid, 0.5, 1, 2.5 and 5 mg / ml of the extract obtained above. 20 uL of a solution dissolved in 1 ml of methanol and 230 uL of a mixture of 20 uL of AChE (0.2 unit) was pretreated at 37 ° C. for 10 minutes, 20 uL of 3.75 mM acetylcholine iodide was added, and then 30 minutes at 37 ° C. The reaction was carried out and the absorbance (A) was measured at 410 nm. In addition, the absorbance (B) was measured at 410 nm of a mixed solution of 20 M of a solution in which 0.1 M phosphate buffer (pH 8.0) and the previously obtained extract were dissolved in 1 ml of methanol at concentrations of 0.5, 1, 2.5 and 5 mg / ml. In addition, as a control, using the absorbance measured in methanol 410nm, AChE inhibitory activity was measured by the following formula (see Table 2).

여러가지 생약재 추출물의 AChE 저해활성(단위: %)AChE Inhibitory Activity of Various Medicinal Herb Extracts (Unit:%) 생약재Herbal medicine 0.5mg/ml0.5mg / ml 1mg/ml1mg / ml 2.5mg/ml2.5mg / ml 5mg/ml5mg / ml 당귀Donkey -- 5.55.5 10.110.1 18.718.7 당삼Dangsam 0.40.4 10.710.7 31.131.1 62.162.1 독활Poisonous -- -- 3.93.9 13.013.0 두충Tofu -- -- 11.511.5 14.614.6 맥문동Macmundong 11.111.1 13.313.3 12.912.9 8.08.0 백작약Earl -- 7.07.0 33.533.5 60.260.2 백출Whiteness -- -- -- 6.56.5 복령Ghost -- -- -- 5.55.5 산사Sansa -- -- 11.511.5 30.630.6 산사자Mountain lion -- -- 2.92.9 15.315.3 상백피White skin 56.256.2 76.376.3 81.981.9 85.985.9 세신Sesin -- -- -- -- 숙지황Hungjiwang -- 1.81.8 6.86.8 8.38.3 원지Paper -- -- -- -- 인산Phosphoric Acid -- -- 1.51.5 16.216.2 진피dermis 11.111.1 -- -- 11.911.9 천궁Cheongung -- 2.92.9 12.812.8 28.928.9 치자Gardenia -- -- 8.08.0 20.020.0 토사자Tosa -- -- 2.32.3 9.29.2 향유enjoyment -- -- 1.91.9 18.718.7

상기 표 2에서 보듯이, 당삼 추출물, 백작약 추출물 및 상백피의 추출물이 우수한 AChE 저해활성을 나타냄을 알 수 있었다. As shown in Table 2, it was found that the extracts of Ginseng extract, Baekjak extract, and the extract of Morus alba showed excellent AChE inhibitory activity.

실시예 2-2: 당삼 추출물, 백작약 추출물 및 상백피 추출물의 혼합시, AChE 저해활성에 대한 상승효과 분석 Example 2-2 : Synergy Analysis of AChE Inhibitory Activity in the Mixing of Ginseng Extract, Baekjak Extract, and Cereal Bark Extract

전기 실시예 2-1에서 수득한 당삼 추출물, 백작약 추출물 및 상백피 추출물을 서로 혼합하였을 때, AChE 저해활성에 대한 상승효과를 나타내는지를 알아보기 위하여, 추출물 농도 1mg/mL과 5mg/mL에서 이들 추출물을 동일한 비율(1:1)로 각각 혼합한 후, AChE에 대한 저해활성을 측정하였다(참조: 표 3): 이때, 상승효과를 비교하기 위하여, 각 성분의 독자적인 AChE에 대한 저해활성을 대조군으로 사용하였다.To determine whether synergistic effect on AChE inhibitory activity was obtained when the Ginseng extract, Baekjak extract and Epidermis extract obtained in Example 2-1 were mixed with each other, these extracts were prepared at the extract concentrations of 1 mg / mL and 5 mg / mL. After mixing at the same ratio (1: 1), the inhibitory activity against AChE was measured (see Table 3). At this time, in order to compare synergistic effects, the inhibitory activity against each component's own AChE was used as a control. It was.

여러가지 생약재 추출물 혼합물의 AChE 저해활성에 대한 상승효과(단위: %)Synergistic effect of AChE inhibitory activity of various herbal extract mixtures (%) 성분ingredient 1mg/ml1mg / ml 5mg/ml5mg / ml 당삼Dangsam 10.710.7 62.162.1 백작약Earl 7.07.0 60.260.2 상백피White skin 76.376.3 85.985.9 상백피:당삼Cereal Skin: Dangsam 79.379.3 97.897.8 상백피:백작약White pear skin: Earl 39.539.5 85.185.1 당삼:백작약Dangsam: White Peony 8.38.3 59.659.6

상기 표 3에서 보듯이, 상백피 추출물과 당삼 추출물을 혼합한 경우에는 상승효과가 나타났으나, 백작약 추출물을 혼합한 경우에는 오히려 저해활성이 감소됨을 알 수 있었으므로, AChE 저해활성을 나타내기 위하여는, 상백피 추출물과 당삼 추출물을 혼합하여 사용함이 바람직함을 알 수 있었다.As shown in Table 3, the synergistic effect was shown when mixed with the extract of baekbaekpi and sugar extract, but it was found that the inhibitory activity is reduced when mixing the extract of Baekjak, in order to show the AChE inhibitory activity , It was found that it is preferable to use a mixture of lettuce extract and Dangsam extract.

실시예 2-3: 민들레 추출물, 당삼 추출물 및 상백피 추출물의 혼합시, AChE 저해활성에 대한 상승효과 분석 Example 2-3 : Synergy Analysis of AChE Inhibitory Activity in Mixing Dandelion Extract, Ginseng Extract, and Morus Cortex Extract

전기 상백피 추출물과 당삼 추출물의 혼합물에 민들레 추출물을 추가할 경우, AChE 저해활성에 대한 상승효과를 나타내는 지의 여부를 확인하였다: 즉, 전기 실시예 1-1에서 수득한 민들레 추출물을 1mg/ml 및 5mg/ml의 농도로 메탄올에 용해시키고, 동일한 농도의 상백피 추출물 및 당삼 추출물과 다양한 혼합비(10:0, 7:3, 5:5, 3:7 및 0:10(v/v))로 혼합한 후, 이의 AChE 저해활성을 측정하였다(참조: 표 4a, 표 4b, 표 4c).When adding dandelion extract to the mixture of the extracts of the extract from the former extract and the ginseng extract, it was confirmed whether the synergistic effect on the AChE inhibitory activity: ie 1mg / ml and 5mg of the dandelion extract obtained in Example 1-1 dissolved in methanol at a concentration of / ml, and mixed with the same concentrations of the extracts of the extract of baekhyeol and ginseng in various mixing ratios (10: 0, 7: 3, 5: 5, 3: 7 and 0:10 (v / v)) Then, its AChE inhibitory activity was measured (see Table 4a, Table 4b, Table 4c).

민들레 추출물 및 상백피 추출물의 혼합비에 따른 AChE 저해활성에 대한 상승효과(단위: %)Synergistic Effect on AChE Inhibitory Activity According to the Mixing Ratio of Dandelion Extract and Morus Cortex Extract (Unit:%) 혼합비(민들레:상백피)Mixed ratio (dandelion: baekbaekpi) 1mg/ml1mg / ml 5mg/ml5mg / ml 10:010: 0 -5.1-5.1 -9.5-9.5 7:37: 3 73.073.0 90.890.8 5:55: 5 85.985.9 96.396.3 3:73: 7 78.078.0 95.695.6 0:100:10 76.376.3 85.985.9

민들레 추출물 및 당삼 추출물의 혼합비에 따른 AChE 저해활성에 대한 상승효과(단위: %)Synergistic Effect on AChE Inhibitory Activity According to the Mixing Ratio of Dandelion Extract and Ginseng Extract (Unit:%) 혼합비(민들레:당삼)Mixed ratio (dandelion: Dangsam) 1mg/ml1mg / ml 5mg/ml5mg / ml 10:010: 0 -5.1-5.1 -9.5-9.5 7:37: 3 13.413.4 70.770.7 5:55: 5 16.316.3 77.877.8 3:73: 7 11.111.1 64.364.3 0:100:10 10.710.7 62.162.1

상백피 추출물 및 당삼 추출물의 혼합비에 따른 AChE 저해활성에 대한 상승효과(단위: %)Synergistic Effect on AChE Inhibitory Activity According to the Mixing Ratio of Morus bark Extract and Ginseng Extract (Unit:%) 혼합비(상백피:당삼)Mixing ratio (Skin white: Ginseng) 1mg/ml1mg / ml 5mg/ml5mg / ml 10:010: 0 76.376.3 85.985.9 7:37: 3 89.189.1 100.7100.7 5:55: 5 79.379.3 97.897.8 3:73: 7 78.178.1 94.394.3 0:100:10 10.710.7 62.162.1

상기 표 4a 내지 4c에서 보듯이, 민들레 추출물을 단독으로 사용하여 1mg/mL와 5mg/mL의 농도에서 저해율을 조사한 결과, 각각 -5.1%와 -9.5%를 나타내어 민들레 추출물은 AChE에 대한 저해활성이 없는 것으로 나타났다. 그러나, 민들레 추출물을 상백피 추출물과 혼합하거나 또는 당삼 추출물과 혼합한 경우에는, 원래의 상백피 추출물 또는 당삼 추출물의 저해율보다 유사하거나 또는 높은 정도의 저해율을 나타냄을 알 수 있었다. 아울러, 상백피 추출물과 당삼 추출물을 혼합한 경우에도, 상승효과를 나타냄을 알 수 있었다.As shown in Tables 4a to 4c, using the dandelion extract alone, the inhibition rate at concentrations of 1 mg / mL and 5 mg / mL was -5.1% and -9.5%, respectively, indicating that the dandelion extract had inhibitory activity against AChE. Turned out to be absent. However, when the dandelion extract is mixed with the extract of the lettuce extract or the sugar extract, it can be seen that the inhibition rate is similar to or higher than that of the original extract of the extract. In addition, it was found that the synergistic effect was obtained even when the extract of Morus alba extract and Ginseng extract.

실시예 3: 생약성분이 함유된 민들레 과립차 및 그의 치매예방효과 분석 Example 3 Analysis of Dandelion Granule Tea Containing Medicinal Herbs and its Dementia Prevention Effects

상기 실시예 2-3의 결과에서 보듯이, 민들레 추출물, 상백피 추출물 및 당삼 추출물을 각각 혼합할 경우, AChE 저해활성에 대하여 상승효과를 나타냄을 확인할 수 있었는 바, 민들레를 주재로 한 과립차를 제조하고, 이에 상백피 추출물과 당삼 추출물을 각각 또는 함께 첨가할 경우, 제조된 민들레 과립차가 치매 예방효과를 나타낼 수 있는 지를 확인하였다.As shown in the result of Example 2-3, when the dandelion extract, lettuce extract and sugar extract were mixed, respectively, it was confirmed that the synergistic effect on the AChE inhibitory activity, to prepare a granule tea based on dandelion In addition, it was confirmed whether the dandelion granule tea prepared by the addition of the baekbaekpi extract and the ginseng extract, respectively, can exhibit a dementia prevention effect.

실시예 3-1: 민들레 과립차의 제조 Example 3-1 Preparation of Dandelion Granulated Tea

1kg의 수세된 노랑 민들레 잎을 적당한 크기로 절단하고, 65℃에서 건조시킨 다음, 약 0.3cm의 크기로 각각 분쇄하였다. 분쇄물을 60mesh의 베 재질의 천에 싸고 분쇄물 중량의 6배의 물을 가하여 90℃에서 6시간 동안 추출한 다음, 추출액을 200mesh의 체로 여과하고, 여과액을 당도가 60°Brix가 될 때까지 농축시켜서, 60°Brix의 민들레 잎 추출액을 수득하였다. 이어, 포도당 100중량부와 민들레 잎 추출액 15중량부를 혼합하여 혼합물을 수득하고, 이를 45℃에서 열풍건조하여 각각의 민들레 과립차를 제조하고, 이를 대조군으로 사용하였다. 1 kg of washed yellow dandelion leaves were cut to an appropriate size, dried at 65 ° C., and then ground to a size of about 0.3 cm. The pulverized product was wrapped in a 60-mesh cloth, and 6 times the weight of the pulverized material was added, followed by extraction at 90 ° C. for 6 hours. The extract was filtered through a 200-mesh sieve, and the filtrate was heated to 60 ° Brix. Concentration gave a Dandelion leaf extract of 60 ° Brix. Subsequently, 100 parts by weight of glucose and 15 parts by weight of the dandelion leaf extract were mixed to obtain a mixture, which was then hot-air dried at 45 ° C. to prepare respective dandelion granulated tea, which was used as a control.

이어, 1kg의 상백피를 대상으로 한 것을 제외하고는, 상기 민들레 잎 추출액을 수득하는 방법과 동일한 방법을 이용하여, 60°Brix의 상백피 추출액을 수득한 후, 전기 포도당 100중량부와 민들레 잎 추출액 15중량부의 혼합물에 각각 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15 및 20중량부를 첨가하여, 상백피가 함유된 민들레 과립차(실험군 1-1 내지 1-12)를 각각 제조하였다.Subsequently, except for 1 kg of baekryepi, using the same method as the method of obtaining the dandelion leaf extract, after extracting the extract of 60 ° Brix, 100 parts by weight of electric glucose and dandelion leaf extract 15 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, and 20 parts by weight were added to the mixture by weight, respectively, to obtain dandelion granule tea (Experimental groups 1-1 to 1-12) containing baekbaekpi. Each was prepared.

또한, 1kg의 당삼을 대상으로 한 것을 제외하고는, 상기 민들레 잎 추출액을 수득하는 방법과 동일한 방법을 이용하여, 60°Brix의 당삼 추출액을 수득한 후, 전기 포도당 100중량부와 민들레 잎 추출액 15중량부의 혼합물에 각각 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15 및 20중량부를 첨가하여, 당삼이 함유된 민들레 과립차(실험군 2-1 내지 2-12)를 각각 제조하였다.Also, except for 1 kg of ginseng, the same method as that of the dandelion leaf extract was obtained, and then 60 g Brix sugar extract was obtained, followed by 100 parts by weight of electric glucose and the dandelion leaf extract 15. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, and 20 parts by weight were added to the mixture by weight, respectively, to prepare dandelion granule tea (Experimental group 2-1 to 2-12) containing ginseng. Each was prepared.

아울러, 전기 수득한 상백피 추출액과 당삼 추출액을 전기 포도당 100중량부와 민들레 잎 추출액 15중량부의 혼합물에 각각 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15 및 20중량부씩 동시에 첨가하여, 상백피와 당삼이 함유된 민들레 과립차(실험군 3-1 내지 3-12)를 각각 제조하였다.In addition, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, and 20 weights of the previously obtained extracts from the extracts of baekhyeolpi and the ginseng extract were mixed with 100 parts by weight of electric glucose and 15 parts by weight of dandelion leaf extract, respectively. Simultaneous addition was performed to prepare dandelion granule tea (Experimental Group 3-1 to 3-12) each containing lettuce and red ginseng.

실시예 3-2: 민들레 과립차의 치매예방효과 분석 Example 3-2 Analysis of Prevention of Dementia of Dandelion Granulated Tea

전기 실시예 3-1에서 수득한 각 실험군의 민들레 과립차 5㎎을 50㎖의 물에 용해시켜서 사용하는 것을 제외하고는, 전기 실시예 1-2의 방법을 사용하여, 신경세포의 생존율을 측정하였다(참조: 표 5). 이때, 제 1대조군으로는 βA와 민들레 과립차가 처리되지 않은 신경세포를 사용하고, 제 2대조군으로는 βA만이 처리된 신경세포를 사용하였으며, 제 3대조군으로는 βA와 전기 실시예 3-1에서 제조된 대조군 민들레 과립차가 처리된 신경세포를 사용하였다.Survival rate of neurons was measured using the method of Example 1-2, except that 5 mg of dandelion granulated tea of each experimental group obtained in Example 3-1 was dissolved in 50 ml of water and used. (See Table 5). In this case, the first control group used neurons without βA and dandelion granular tea, the second control group used neurons treated with only βA, and the third control group with βA and the previous Example 3-1 Neurons treated with the prepared control dandelion granule tea were used.

각 민들레 과립차가 처리된 신경세포의 생존율(단위: %)Survival rate of neurons treated with each dandelion granule tea (%) 실험군Experimental group 생존율Survival rate 실험군Experimental group 생존율Survival rate 실험군Experimental group 생존율Survival rate 제 1대조군실험군 1-1실험군 1-2실험군 1-3실험군 1-4실험군 1-5실험군 1-6실험군 1-7실험군 1-8실험군 1-9실험군 1-10실험군 1-11실험군 1-121st control group 1-1 Experiment group 1-2 Experiment group 1-3 Experiment group 1-4 Experiment group 1-5 Experiment group 1-6 Experiment group 1-7 Experiment group 1-8 Experiment group 1-9 Experiment group 1-10 Experiment group 1-11 Experiment group 1- 12 100656768727578838891939393100656768727578838891939393 제 2대조군실험군 2-1실험군 2-2실험군 2-3실험군 2-4실험군 2-5실험군 2-6실험군 2-7실험군 2-8실험군 2-9실험군 2-10실험군 2-11실험군 2-122nd control group 2-1 Experiment group 2-2 Experiment group 2-3 Experiment group 2-4 Experiment group 2-5 Experiment group 2-6 Experiment group 2-7 Experiment group 2-8 Experiment group 2-9 Experiment group 2-10 Experiment group 2-11 Experiment group 2- 12 6065676972747680848688888860656769727476808486888888 제 3대조군실험군 3-1실험군 3-2실험군 3-3실험군 3-4실험군 3-5실험군 3-6실험군 3-7실험군 3-8실험군 3-9실험군 3-10실험군 3-11실험군 3-123rd control group 3-1 Experiment group 3-2 Experiment group 3-3 Experiment group 3-4 Experiment group 3-5 Experiment group 3-6 Experiment group 3-7 Experiment group 3-8 Experiment group 3-9 Experiment group 3-10 Experiment group 3-11 Experiment group 3- 12 6369736679818488929598989863697366798184889295989898

상기 표 5에서 보듯이, 민들레 과립차는 그 자체(제 3대조군)로도 신경세포의 생존율을 향상시킬 수 있으며, 상백피 추출액 또는 당삼 추출액이 첨가될 경우에는 전체적으로 신경세포의 생존율이 증가시키는 상승효과를 나타냄을 알 수 있었다. 아울러, 상백피 추출액과 당삼 추출액을 10중량부 이상의 함량으로 첨가할 경우(실험군 1-11, 1-12, 2-11, 2-12, 3-11 및 3-12), 더 이상 생존율 향상효과가 나타나지 않음을 알 수 있었다.As shown in Table 5, the dandelion granule tea can improve the survival rate of the neurons even by itself (third control), when synergistic extract or the extract of Ginseng extract shows a synergistic effect to increase the overall survival rate of neurons And it was found. In addition, when the extracts of the extracts of baekbaekpi and ginseng were added in an amount of 10 parts by weight or more (experimental groups 1-11, 1-12, 2-11, 2-12, 3-11 and 3-12), the survival rate was further improved. It did not appear.

실시예 3-3: 민들레 과립차의 관능검사 Example 3-3 : Sensory test of dandelion granulated tea

전기 실시예 3-1에서 제조된 각 민들레 과립차 200㎎을 70℃의 온수 100㎖에 용해시키고, 이를 20명의 관능검사요원이 9점 채점법(1점: 가장 나쁨, 2점: 매우 나쁨, 3점: 나쁨, 4점: 좋지 않음, 5점: 보통, 6점: 양호함, 7점: 좋음, 8점: 매우 좋음, 9점: 가장 좋음)으로 관능검사를 수행하였다(참조: 표 6a, 표 6b, 표 6c): 이때, 대조군으로는 전기 실시예 3-1에서 제조된 대조군 민들레 과립차를 사용하였다.200 mg of each dandelion granulated tea prepared in Example 3-1 was dissolved in 100 ml of hot water at 70 ° C., and 20 sensory inspectors were scored 9 points (one point: worst, two points: very bad, three points). : Poor, 4 points: Poor, 5 points: Normal, 6 points: Good, 7 points: Good, 8 points: Very good, 9 points: Best) The sensory test was performed (see Table 6a, table). 6b, Table 6c): At this time, the control dandelion granule tea prepared in Example 3-1 was used as a control.

상백피 추출액이 첨가된 민들레 과립차의 관능검사 결과Sensory Evaluation of Dandelion Granulated Tea Added with Morus alba L. Extract 실험군Experimental group 색택Color flavor 종합기호도General Symbol 대조군실험군 1-2실험군 1-4실험군 1-6실험군 1-8실험군 1-10실험군 1-12Control group 1-2 Experiment group 1-4 Experiment group 1-6 Experiment group 1-8 Experiment group 1-10 Experiment group 1-12 6.66.06.33.02.92.72.66.66.06.33.02.92.72.6 6.66.85.14.84.64.23.76.66.85.14.84.64.23.7 6.86.75.04.43.83.63.66.86.75.04.43.83.63.6

상기 표 6a에서 보듯이, 대조군의 민들레 과립차는 투명하고 노란색을 띄고 있으나, 상백피 추출액의 첨가량이 증가할수록 불투명해지고, 과립차의 색이 진한 갈색으로 변화되는 양상을 나타내었다. 또한, 자극적인 자극적인 냄새와 떫은 맛이 증가하여 맛과 종합적 기호도가 감소하는 경향이 나타났다. 그러나, 실험군 1-1 내지 1-4의 경우, 전체적으로 유의적인 감소를 나타내지 않았다. As shown in Table 6a, the dandelion granule tea of the control group is clear and yellow, but becomes opaque as the amount of the extract added to the extract, the color of the granule tea is changed to a dark brown color. In addition, the irritating irritant smell and astringent taste were increased, the taste and overall preference tended to decrease. However, in the experimental groups 1-1 to 1-4, there was no significant decrease overall.

당삼 추출액이 첨가된 민들레 과립차의 관능검사 결과Sensory Evaluation of Dandelion Granulated Tea Added with Ginseng Extract 실험군Experimental group 색택Color flavor 종합기호도General Symbol 대조군실험군 2-2실험군 2-4실험군 2-6실험군 2-8실험군 2-10실험군 2-12Control group 2-2 Experiment group 2-4 Experiment group 2-6 Experiment group 2-8 Experiment group 2-10 Experiment group 2-12 6.67.07.15.04.94.74.66.67.07.15.04.94.74.6 6.67.87.05.34.64.24.06.67.87.05.34.64.24.0 6.87.77.15.54.84.64.06.87.77.15.54.84.64.0

상기 표 6b에서 보듯이, 당삼 추출액의 첨가량이 증가할 경우에도, 색이 변색되었으나, 상백피 추출액이 첨가된 경우와는 달리, 탁도가 증가되지 않았으며, 색깔만이 진한 갈색으로 변색됨을 알 수 있었다. 또한, 당삼 추출액의 첨가량이 증가할 경우, 자극적인 냄새가 증가되었으나, 상백피 추출액이 첨가된 경우와는 달리, 떫은 맛은 증가되지 않았으므로, 맛과 종합적 기호도가 완만하게 감소하는 경향이 나타났다. 그러나, 실험군 2-1 내지 2-4의 경우, 전체적으로 유의적인 감소를 나타내지 않았다. As shown in Table 6b, even when the added amount of the extract was increased, the color was changed, but unlike when the extract was added, turbidity was not increased, only the color was changed to dark brown. . In addition, when the added amount of the extract was increased, the irritating smell was increased, but unlike when the extract was added, the astringent taste did not increase, the taste and overall preference tended to decrease slowly. However, for the experimental groups 2-1 to 2-4, there was no significant decrease overall.

상백피 추출액과 당삼 추출액이 첨가된 민들레 과립차의 관능검사 결과Sensory Test Results of Dandelion Granule Tea Added with Extracts of Morus alba L. 실험군Experimental group 색택Color flavor 종합기호도General Symbol 대조군실험군 3-1실험군 3-2실험군 3-3실험군 3-4실험군 3-5Control group 3-1 Experiment group 3-2 Experiment group 3-3 Experiment group 3-4 Experiment group 3-5 6.66.76.45.45.34.16.66.76.45.45.34.1 6.67.67.36.96.45.16.67.67.36.96.45.1 6.87.37.06.65.94.66.87.37.06.65.94.6

상기 표 6c에서 보듯이, 상백피 추출액과 당삼 추출액을 첨가할 경우에도, 상기 표 6a 및 6b와 동일한 동일한 양상을 나타내었다.As shown in Table 6c, even when added to the extract extract and the extract of Ginseng, the same aspect as in Tables 6a and 6b.

그러나, 전체적으로 대조군을 비롯한 각 실험군의 민들레 과립차의 기호성이 낮음을 알 수 있었는데, 이는 민들레 잎 고유의 비린내와 풀냄새 그리고 약간의 구린내 등이 나타났기 때문인 것으로 판단되었다.However, it was found that the palatability of the dandelion granule tea of each experimental group including the control group was low, because the dandelion leaf's own fishy smell, grass smell, and slight burniness appeared.

실시예 3-4: 민들레 뿌리 추출액을 함유하는 민들레 과립차의 제조 및 그의 관능검사 Example 3-4 Preparation of Dandelion Granulated Tea Containing Dandelion Root Extract and Its Sensory Evaluation

전기 실시예 3-3에서, 전술한 바와 같이, 민들레 잎 추출액, 상백피 추출액, 당삼 추출액 및 포도당을 포함하는 민들레 과립차에서는 민들레 잎 고유의 비린내와 풀냄새 그리고 약간의 구린내 등이 나타났으므로, 민들레 뿌리에서 수득한 추출액을 첨가하여 기호성을 향상시키고자 하였다.In the above Example 3-3, as described above, the dandelion granulated tea including dandelion leaf extract, lettuce extract, glucose extract and glucose showed inherent fishy smell, grassy smell and slight burniness, and thus, dandelion root. To improve the palatability by the addition of the extract obtained in.

즉, 1kg의 수세된 노랑 민들레 뿌리를 사용하는 것을 제외하고는, 실시예 3-1에 개시된 방법을 사용하여, 60°Brix의 민들레 뿌리 추출액을 수득하였다. 이어, 포도당 100중량부, 전기 수득한 상백피 추출액 2중량부, 당삼 추출액 2중량부 및 민들레 잎 추출액과 민들레 뿌리 추출액을 혼합한 민들레 추출액 혼합물 15중량부를 혼합하여, 혼합물을 수득하고, 이를 45℃에서 열풍건조하여 각각의 민들레 과립차를 제조하고, 제조된 각각의 과립차 30g을 70℃의 온수에 용해시키고, 이를 20명의 관능검사요원이 9점 채점법으로 관능검사를 수행하였다. 이때, 민들레 추출액 혼합물은 잎 추출액과 뿌리 추출액이 각각 1:1(실험군 a), 2:1(실험군 b), 3:1(실험군 c), 4:1(실험군 d) 및 5:1(실험군 e)(w/w)로 혼합된 것을 사용하고, 대조군으로는, 전기 민들레 혼합물이 첨가되지 않은 과립차를 사용하였다(참조: 표 7a).That is, a dandelion root extract of 60 ° Brix was obtained using the method described in Example 3-1, except that 1 kg of washed yellow dandelion roots were used. Subsequently, 100 parts by weight of glucose, 2 parts by weight of the extract of lettuce extract, 2 parts by weight of ginseng extract, and 15 parts by weight of the dandelion extract mixture of dandelion leaf extract and dandelion root extract were mixed to obtain a mixture, which was obtained at 45 ° C. Each dandelion granulated tea was prepared by hot air drying, and 30 g of each granulated tea was dissolved in warm water at 70 ° C., and 20 sensory test personnel carried out a sensory test using a nine-point scoring method. At this time, the dandelion extract mixture of leaf extract and root extract 1: 1 (experimental group a), 2: 1 (experimental group b), 3: 1 (experimental group c), 4: 1 (experimental group d) and 5: 1 (experimental group), respectively. e) a mixture of (w / w) was used, and as a control, a granular tea was used without adding the dandelion mixture (see Table 7a).

민들레 추출액 혼합물의 혼합비에 따른 민들레 과립차의 관능검사 결과Sensory Test Results of Dandelion Granule Tea with Mixture Ratio of Dandelion Extract Mixtures 실험군Experimental group 색택Color flavor 종합기호도General Symbol 대조군실험군 a실험군 b실험군 c실험군 d실험군 eControl group a Experiment group b Experiment group c Experiment group d Experiment group e 1.64.75.07.67.16.81.64.75.07.67.16.8 1.64.64.87.76.86.11.64.64.87.76.86.1 1.84.66.17.96.96.61.84.66.17.96.96.6

상기 표 7a에서 보듯이, 민들레의 잎 추출액과 민들레 뿌리 추출액의 혼합비율은 3:1(실험군 c)(w/w)인 경우에 관능특성이 가장 우수함을 알 수 있었다.As shown in Table 7a, the mixing ratio of the dandelion leaf extract and the dandelion root extract was found to be the most excellent sensory properties when the 3: 1 (experimental group c) (w / w).

이어, 전기 선별된 비율로 혼합된 민들레 추출액 혼합물의 첨가량을 변화시켜서, 가장 우수한 관능특성을 나타내는 민들레 과립차의 조성을 결정하고자 하였다. 즉, 포도당 100중량부, 전기 수득한 상백피 추출액 2중량부 및 당삼 추출액 2중량부의 혼합물에, 민들레 잎 추출액과 뿌리 추출액이 3:1(w/w)로 혼합된 민들레 혼합물을 각각 10중량부(실험군 f), 12중량부(실험군 g), 14중량부(실험군 h), 16중량부(실험군 i), 18중량부(실험군 j) 및 20중량부(실험군 k)를 첨가하였으며, 이를 45℃에서 열풍건조하여 각각의 민들레 과립차를 제조하고, 제조된 각각의 과립차 200㎎을 70℃의 온수 100㎖에 용해시켰으며, 이를 20명의 관능검사요원이 9점 채점법으로 관능검사를 수행하였다. 이때, 대조군으로는, 전기 민들레 혼합물이 첨가되지 않은 과립차를 사용하였다(참조: 표 7b).Subsequently, the addition amount of the dandelion extract mixture mixed at the selected ratio was varied to determine the composition of the dandelion granule tea showing the best sensory properties. That is, in the mixture of 100 parts by weight of glucose, 2 parts by weight of the extract of the lettuce extract, and 2 parts by weight of the ginseng extract, 10 parts by weight of the dandelion mixture each having a dandelion leaf extract and a root extract of 3: 1 (w / w) Experimental group f), 12 parts by weight (experimental group g), 14 parts by weight (experimental group h), 16 parts by weight (experimental group i), 18 parts by weight (experimental group j) and 20 parts by weight (experimental group k) were added, which was 45 ° C. Each dandelion granule tea was prepared by hot air drying at 200 mg, and 200 mg of each granulated tea was dissolved in 100 ml of hot water at 70 ° C., and 20 sensory test personnel performed sensory tests using a nine-point scoring method. At this time, as a control, a granular tea was used without adding the dandelion mixture (see Table 7b).

민들레 혼합물의 함량에 따른, 민들레 과립차의 관능검사 결과Sensory Test Results of Dandelion Granulated Tea by Contents of Dandelion Mixture 실험군Experimental group 색택Color flavor 종합기호도General Symbol 대조군실험군 f실험군 g실험군 h실험군 i실험군 j실험군 kControl group Experiment group f Experiment group g Experiment group h Experiment group i Experiment group j Experiment group k 1.65.77.08.48.47.16.91.65.77.08.48.47.16.9 1.65.68.29.78.77.16.91.65.68.29.78.77.16.9 1.85.68.18.98.47.16.81.85.68.18.98.47.16.8

상기 표 7b에서 보듯이, 민들레의 잎 추출액과 뿌리 추출액이 3:1(w/w)로 혼합된 민들레 추출액 혼합물이 12중량부 내지 16중량부로 첨가된 경우에, 관능특성이 가장 우수함을 알 수 있었다.As shown in Table 7b, when the dandelion extract mixture of the dandelion leaf extract and the root extract is mixed 3: 1 (w / w) is added to 12 parts by weight to 16 parts by weight, it can be seen that the sensory properties are the best there was.

따라서, 전기 표 7a 및 표 7b의 결과를 종합하면, 가장 우수한 관능특성을 나타내는 민들레 잎 추출액의 함량은 9 내지 12중량부이고, 민들레 뿌리 추출액의 함량은 3 내지 4중량부임을 알 수 있었다. Therefore, when the results of Tables 7a and 7b were combined, it was found that the content of the dandelion leaf extract showing the best sensory properties was 9 to 12 parts by weight, and the content of the dandelion root extract was 3 to 4 parts by weight.

이상의 결과를 종합하여 볼 때, 치매예방 효능을 갖는 민들레 과립차는 당류 100중량부, 민들레 잎 추출액 9 내지 12중량부, 민들레 뿌리 추출액 3 내지 4중량부, 상백피 추출액 2 내지 4중량부 및 당삼 추출액 2 내지 4중량부의 비율로 포함하는 것임을 확인할 수 있었다.Based on the above results, dandelion granule tea having an effect of preventing dementia is 100 parts by weight of saccharides, 9 to 12 parts by weight of dandelion leaf extract, 3 to 4 parts by weight of dandelion root extract, 2 to 4 parts by weight of lettuce extract and sugar extract 2 To 4 parts by weight was confirmed to include.

이상에서 상세히 설명하고 입증하였듯이, 본 발명은 민들레 잎 추출물, 민들레 뿌리 추출물, 상백피 추출물 및 당삼 추출물을 포함하는 민들레 과립차 및 그의 제조방법을 제공한다. 본 발명의 민들레 과립차는 치매예방효과가 우수할 뿐만 아니라, 기호성이 우수하므로, 치매예방을 위한 기능성 식품으로서 널리 활용될 수 있을 것이다.As described and demonstrated in detail above, the present invention provides a dandelion granule tea comprising the dandelion leaf extract, dandelion root extract, lettuce extract and sugar extract and a method for producing the same. Dandelion granule tea of the present invention is not only excellent dementia prevention effect, but also excellent palatability, it can be widely used as a functional food for preventing dementia.

Claims (2)

(ⅰ) 포도당 100중량부, 50 내지 70Brix의 민들레 잎 열수추출액 9 내지 12중량부, 50 내지 70Brix의 민들레 뿌리 열수추출액 3 내지 4중량부, 50 내지 70Brix의 상백피 열수추출액 2 내지 4중량부 및 50 내지 70Brix의 당삼 열수추출액 2 내지 4중량부를 혼합하는 공정;(Iii) 100 parts by weight of glucose, 9 to 12 parts by weight of dandelion leaf hot water extract of 50 to 70 Brix, 3 to 4 parts by weight of dandelion root hot water extract of 50 to 70 Brix, 2 to 4 parts by weight of hot water extract of 50 to 70 Brix Mixing 2 to 4 parts by weight of the sugar ginseng hot water extract of 70-Brix; (ⅱ) 전기 혼합물을 농축하고 제립하여, 과립을 수득하는 공정; 및,(Ii) concentrating and granulating the mixture to obtain granules; And, (ⅲ) 전기 수득한 과립을 건조시키는 공정을 포함하는, 민들레 과립차의 제조방법.(Iii) A method for producing a dandelion granule tea, comprising the step of drying the granules obtained previously. 제 1항의 방법으로 제조되어, 당류 100중량부, 민들레 잎 추출물 9 내지 12중량부, 민들레 뿌리 추출물 3 내지 4중량부, 상백피 추출물 2 내지 4중량부 및 당삼 추출물 2 내지 4중량부를 포함하고, 치매예방 효과를 나타내는 민들레 과립차.Prepared by the method of claim 1, comprising 100 parts by weight of sugar, 9 to 12 parts by weight of dandelion leaf extract, 3 to 4 parts by weight of dandelion root extract, 2 to 4 parts by weight of lettuce extract and 2 to 4 parts by weight of sugar extract, dementia Dandelion granulated tea with a protective effect.
KR1020040038613A 2004-05-29 2004-05-29 Dandelion granular tea and process for preparing the same KR100526944B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020040038613A KR100526944B1 (en) 2004-05-29 2004-05-29 Dandelion granular tea and process for preparing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040038613A KR100526944B1 (en) 2004-05-29 2004-05-29 Dandelion granular tea and process for preparing the same

Publications (1)

Publication Number Publication Date
KR100526944B1 true KR100526944B1 (en) 2005-11-08

Family

ID=37305917

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020040038613A KR100526944B1 (en) 2004-05-29 2004-05-29 Dandelion granular tea and process for preparing the same

Country Status (1)

Country Link
KR (1) KR100526944B1 (en)

Similar Documents

Publication Publication Date Title
KR101382099B1 (en) Anticonvulsive compositions comprising aster glehni extract, fractions thereof, or compounds isolated from thereform
KR101898688B1 (en) Composition for preventing, treating or improving muscle atrophy comprising complex extracts
KR20130003520A (en) Composition for preventing or relieving alcohol-induced hangover comprising medicinal herbs
JP2008528481A (en) Composition comprising a complex herbal extract having neuroprotective activity for the prevention and treatment of stroke and neurodegenerative diseases
KR20020015540A (en) Food materials for preventing dementia and foods using the same
KR101617590B1 (en) Antiobesity Food Composition Comprising Extract of Aronia, Acaiberry and Stevia
WO2009110546A1 (en) Composition containing aqueous extract of ashwaganda leaves as the active ingredient and method of producing the same
JP2005538131A (en) Cistanchedesertica Y. enhances neurite outgrowth and neurotrophic activity. C. Composition containing MA extract
KR100526945B1 (en) Dandelion anulus and process for preparing the same
CN103999986A (en) Herbal tea concentrated juice and preparation method thereof
KR100560198B1 (en) Dandelion Kimchi and Process for Preparing the Same
KR20090103239A (en) A composition comprising the extract belonged to Vitidis Viniferae Radix being effective asthmatic or COPD
KR100526944B1 (en) Dandelion granular tea and process for preparing the same
CN109589400A (en) A kind of composition with neuroprotective efficacy
KR20200042325A (en) Liquid composition for stick-type container comprising active mountain-cultivated ginseng extract having increased ginsenosides of human body absorption type, and preparation method thereof
JPH04300836A (en) Hepatic dysfunction preventive agent and functional food having preventive action on hepatic dysfunction
KR101248378B1 (en) Pharmaceutical composition for arthritis treatment and prevention
CN103153323A (en) Composition for promoting memory and learning ability
KR20120053604A (en) Composition for preventing or treating the brain ischemia disease containing extract of codonopsis lanceolata
KR100642801B1 (en) Anti-diabetic food composition comprising extracts from natural herbal materials and pear and process for preparing the same
KR20050005630A (en) Lonicera japonica extract having activity of enhancing IGF-1 secretion, its process method, and application
KR101431798B1 (en) Composition for improvement of learning and memory function comprising non-anthocyanin fraction of black bean husk extract as effective component
KR102247068B1 (en) Composition for the prevention and treatment of degenerative brain disease comprising bohyulanshin-tang
KR101446962B1 (en) New variety of blackberry, 'Amor' and Composition containing extract of the same
KR20110080998A (en) Composition for improving wrinkle and elasticity containing black currant anthocyanins

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130415

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20131028

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20141201

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20150904

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20161101

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20171027

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20180928

Year of fee payment: 14